Home Sectors Industrials Current Technicals: Impax Laboratories (NASDAQ: IPXL)

Current Technicals: Impax Laboratories (NASDAQ: IPXL)


Impax Laboratories is in the sector and is part of the industry.

Previous Intraday Trading Performance:

The IPXL stock showed a previous change of 0.00% with an open at 18.20 and a close of 18.30. It reached an intraday high of 18.95 and a low of 17.40.

PR Newswire:  ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax


The stock has a market cap of $0 with 0 shares outstanding, of which the float is 0 shares. Trading volume reached 3,066,017 shares compared to its average volume of 821,879 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.

Historical Trading Performance:

Over the last five trading days, Impax Laboratories shares returned -2.66% and in the past 30 trading days it returned -7.11%. Over three months, it changed -8.50%. In one year it has changed 36.06% and within that year its 52-week high was 25.70 and its 52-week low was 13.05. IPXL stock is 40.23% above its 52 Week Low.

Our calculations show a 200 day moving average of 19.16 and a 50 day moving average of 19.60. Currently IPXL stock is trading -4.48% below its 200 day moving average and may be a good opportunity to buy, but should check other indicators to confirm a buy signal.

PR Newswire:  ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax


The last annual fiscal EPS for the company was reported at 0 that ended on 1st of January 1970, which according to the previous close, that is a PE of inf. Based on 5 analyst estimates, the consensus EPS for the next quarter is 0.16. The TTM EPS is 0.63, which comes to a TTM PE of 29.05.

The following are the last four quarter reported earnings per share:
12-31-2017:  0.11
09-30-2017:  0.23
06-30-2017:  0.18
03-31-2017:  0.11

Indicators to Watch:

Short-interest is 8,917,363, which is inf% of shares outstanding. The short-interest ratio or days-to-cover ratio is 11.87.

The current calculated beta is 1.14

Business Wire:  Iconix Brand Group, Inc. Names John T. McClain as CFO

Fundamental Indicators:

Company Scores:

All scores are out of six:
 3  :Valuation Score
 3  :Past Performance Score
 4  :Financial Strength Score
 4  :Future Growth Score
 0  :Dividend Score
 3  :Overall Score

John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.